An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Medical Case Reports | Volume-5 | Issue-12
Treatment of Oral Hemangioma with 1%Tétradécyl Sulfate De Sodium: Case Report
Amani Aroua, Radhia Ben Ali, Hentati Hajer, Jamil Selmi
Published: Dec. 30, 2017 | 132 152
DOI: 10.36347/sjmcr.2017.v05i12.008
Pages: 837-840
Downloads
Abstract
Hemangioma, is benign vascular lesions, common in the head and neck regions, but relatively rare in the oral cavity. The most common site is the upper lip, but they can occur in other areas, such as the tongue, buccal mucosa and palate. Hemangiomas possess an extremely challenging treatment dilemma for surgeons and the patients. Treatment is primarily dependent on correct diagnosis of the lesion and on its anatomic location. Oral hemangioma can be treated with sclerotherapy, systemic corticosteroids, interferon α, laser, embolization, cryotherapy and surgery. The purpose of this article is to provide a description of a case of a hemangioma on the lower lip, treated by therapeutic sclerosis with Sodium tetradecyl sulfate (1 %) (Trombovar). Hemangioma regressed with considerable relief of symptoms with minimal complications. When used in appropriate doses, Sclerosing agent, 1%Sodium tetradecyl sulfate (STS), is very effective for treatment of oral hemangioma.